WBH Advisory’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

WBH Advisory’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-3,794	Closed	-$224K	–	205
2015 Q2	$224K	Hold	3,794	–	–	0.09%	183
2015 Q1	$236K	Sell	3,794 -50	-1%	-$2.91K	0.07%	186
2014 Q4	$221K	Sell	3,844 -200	-5%	-$11.1K	0.08%	188
2014 Q3	$217K	Buy	4,044 +66	+2%	+$3.5K	0.08%	196
2014 Q2	$208K	Hold	3,978	–	–	0.08%	201
2014 Q1	$210K	Buy	+3,978	New	+$184K	0.08%	201
2013 Q4	–	Sell	-7,150	Closed	-$270K	–	205
2013 Q3	$270K	Sell	7,150 -550	-7%	-$21.5K	0.12%	160
2013 Q2	$301K	Buy	+7,700	New	+$300K	0.14%	149

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

WBH Advisory's TEVA Position: Q3 2015 in Review

WBH Advisory sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q3 2015, closing a stake of 3,794 shares — an estimated $224K sold.

WBH Advisory first reported a position in TEVA in Q2 2013 and held it in 8 quarters. The position peaked at $301K in Q2 2013. 824 funds tracked by Wall St. Rank hold TEVA as of Q3 2015.

WBH Advisory reported no remaining Teva Pharmaceutical Industries Limited position as of Q3 2015 after selling out during the quarter.
WBH Advisory sold 3,794 Teva Pharmaceutical Industries Limited shares in Q3 2015, an estimated $224K.
WBH Advisory first reported a position in Teva Pharmaceutical Industries Limited in Q2 2013 and held it in 8 quarters.
WBH Advisory's Teva Pharmaceutical Industries Limited position peaked at $301K in Q2 2013.
824 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2015.

Based on WBH Advisory's 13F filing for Q3 2015, filed 15 Oct 2015.